<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57617</article-id><article-id pub-id-type="doi">10.7554/eLife.57617</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-150898"><name><surname>Liu</surname><given-names>Yingqi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3934-0673</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152224"><name><surname>Li</surname><given-names>Lingling</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152219"><name><surname>Liu</surname><given-names>Xiaoqing</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152221"><name><surname>Wang</surname><given-names>Yibo</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152220"><name><surname>Liu</surname><given-names>Lingxia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152222"><name><surname>Peng</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152223"><name><surname>Liu</surname><given-names>Jiayuan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152225"><name><surname>zhang</surname><given-names>Lian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152226"><name><surname>Wang</surname><given-names>Guannan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152227"><name><surname>Li</surname><given-names>Hongyuan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152228"><name><surname>Liu</surname><given-names>Dongxu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152229"><name><surname>Huang</surname><given-names>Baiqu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-152230"><name><surname>Lu</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-152237"><name><surname>Zhang</surname><given-names>Yu</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3702-6541</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">The Key Laboratory of Molecular Epigenetics of the Ministry of Education, Northeast Normal University</institution>, <institution>Northeast Normal University</institution>, <addr-line><named-content content-type="city">Changhcun</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">The Institute of Genetics and Cytology</institution>, <institution>Northeast Normal University</institution>, <addr-line><named-content content-type="city">Changchun</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Changchun Institute of Applied Chemistry</institution>, <institution>Chinese Academy of Sciences</institution>, <addr-line><named-content content-type="city">Changchun</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">School of Science, Faculty of Health and Environmental Sciences</institution>, <institution>Auckland University of Technology</institution>, <addr-line><named-content content-type="city">Auckland</named-content></addr-line>, <country>New Zealand</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-109554"><name><surname>Postovit</surname><given-names>Lynne-Marie</given-names></name><role>Reviewing editor</role><aff><institution>University of Alberta</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>luj809@nenu.edu.cn</email> (JL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>zhangy288@nenu.edu.cn</email> (YZ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>08</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e57617</elocation-id><history><date date-type="received"><day>06</day><month>04</month><year>2020</year></date><date date-type="accepted"><day>25</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Liu et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Liu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57617-v1.pdf"/><abstract><p>Arginine methyltransferase PRMT7 is associated with human breast cancer metastasis. Endosomal FAK signalling is critical for cancer cell migration. Here we identified the pivotal roles of PRMT7 in promoting endosomal FAK signalling activation during breast cancer metastasis. PRMT7 exerted its functions through binding to scaffold protein SHANK2 and catalyzing di-methylation of SHANK2 at R240. SHANK2 R240 methylation exposed ANK domain by disrupting its SPN-ANK domain blockade, promoting in co-accumulation of dynamin2, talin, FAK, cortactin with SHANK2 on endosomes. In addition, SHANK2 R240 methylation activated endosomal FAK/cortactin signals in vitro and in vivo. Consistently, all the levels of PRMT7, methylated SHANK2, FAK Y397 phosphorylation and cortactin Y421 phosphorylation were correlated with aggressive clinical breast cancer tissues. These findings characterize the PRMT7-dependent SHANK2 methylation as a key player in mediating endosomal FAK signals activation, also point to the value of SHANK2 R240 methylation as a target for breast cancer metastasis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31870765</award-id><principal-award-recipient><name><surname>Huang</surname><given-names>Baiqu</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31571317</award-id><principal-award-recipient><name><surname>Lu</surname><given-names>Jun</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31570718</award-id><principal-award-recipient><name><surname>Huang</surname><given-names>Baiqu</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31771335</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yu</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31770825</award-id><principal-award-recipient><name><surname>Lu</surname><given-names>Jun</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>21807098</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Yibo</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007847</institution-id><institution>Natural Science Foundation of Jilin Province</institution></institution-wrap></funding-source><award-id>20180101232JC</award-id><principal-award-recipient><name><surname>Lu</surname><given-names>Jun</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007847</institution-id><institution>Natural Science Foundation of Jilin Province</institution></institution-wrap></funding-source><award-id>20180101234JC</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yu</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007847</institution-id><institution>Natural Science Foundation of Jilin Province</institution></institution-wrap></funding-source><award-id>20200404106YY</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yu</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal works were conducted in accordance with the IACUC guidelines and with the protocol approved by the IACUC at the Northeast Normal University, reference assurance number AP2013011.</p></fn><fn fn-type="other"><p>Human subjects: Human breast tumour specimens were obtained from the Second Hospital of Jilin University, China. All the breast cancer tissue samples were collected from 27 patients enrolled on pathology department of the Second Hospital of Jilin University. All the samples were diagnosed by the pathology department of the Second Hospital of Jilin University to determine the stage and subtype of the breast tumour. This experiment is an immunohistochemical study, no informed consent was needed due to the use of post-diagnostic left-over material. Ethical approval was obtained from the Ethics Review Committee of the Second Hospital of Jilin University (2019-107).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>PDB accession number for SHANK2 structure analyse is pdb5G4X. Analysis of SHANK2 gene expression in human tissues using the Human Protein Atlas data.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Lilja J</collab><collab>Zacharchenko T</collab><collab>Georgiadou M</collab><collab>Jacquemet G</collab><collab>Franceschi N</collab><collab>Peuhu E</collab><collab>Hamidi H</collab><collab>Pouwels J</collab><collab>Martens V</collab><collab>Nia FH</collab><collab>Beifuss M</collab><collab>Boeckers T</collab><collab>Kreienkamp HJ</collab><collab>Barsukov IL</collab><collab>Ivaska J</collab></person-group><year iso-8601-date="2019">2019</year><source>The crystal structure of the SHANK3 N-terminus</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/5G4X">https://www.rcsb.org/structure/5G4X</ext-link><comment>Protein Data Bank, 5G4X</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-57617-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>